TRACE
Trace a source
tape live—manual reviewONevidenceREQUIREDjson/trace.jsontracked horizons1D · 7D · 30D · 90Ddisclaimernot financial advicetape live—manual reviewONevidenceREQUIREDjson/trace.jsontracked horizons1D · 7D · 30D · 90Ddisclaimernot financial advice
publisheddirectional thesisLONGyoutubenot an explicit trade

LLY directional thesis

New data due this year could prove hitting brain plaques early stops Alzheimer's before damage sets in, on top of an already dominant weight loss drug business.

$930.01entry snapshot
pendingcurrent snapshot
— pendingsince mention
“We've got amazing GLP-1 medicines... from clear data out of Eli Lilly, show a 94% reduction in your risk of moving from being pre-diabetic to diabetic.”
7:08claim_id mcl_7b7a46365b563ada8bopen evidence ↗
Classification directional thesis

Human-reviewed public claim.

Evidence span 7:08

Evidence URL, source timestamp, and excerpt are attached to this permanent claim page.

Correction path available

Creators or reviewers can request reclassification, context, or entity corrections without erasing the source record.

Machine-readable claim
{
  "version": "market-claims.v1",
  "claim": {
    "id": "mcl_7b7a46365b563ada8b",
    "url": "/trace/claims/mcl_7b7a46365b563ada8b",
    "status": "PUBLISHED",
    "claimType": "DIRECTIONAL_THESIS",
    "direction": "LONG",
    "claimText": "New data due this year could prove hitting brain plaques early stops Alzheimer's before damage sets in, on top of an already dominant weight loss drug business.",
    "confidence": 0.72,
    "expert": {
      "slug": "investlikebest",
      "displayName": "Invest Like the Best",
      "kind": "PERSON",
      "status": "UNCLAIMED",
      "avatarUrl": "/api/avatars/75a94db5-5",
      "url": "/trace/experts/investlikebest",
      "claimed": false
    },
    "primaryEntity": {
      "kind": "ASSET",
      "assetClass": "EQUITY",
      "symbol": "LLY",
      "name": "LLY",
      "exchange": null,
      "confidence": 0.78
    },
    "evidence": {
      "evidenceUrl": "https://www.youtube.com/watch?v=QVSP8bGm2KQ&t=428s",
      "sourceUrl": "https://youtube.com/watch?v=QVSP8bGm2KQ",
      "timecode": "7:08",
      "startMs": 428000,
      "endMs": null,
      "excerpt": "We've got amazing GLP-1 medicines... from clear data out of Eli Lilly, show a 94% reduction in your risk of moving from being pre-diabetic to diabetic."
    },
    "performance": {
      "entryPrice": 930.01,
      "currentPrice": null,
      "returnPct": null,
      "relativePct": null,
      "method": "PASTE_AUTHOR_PRICE"
    },
    "resolutionStatus": "OPEN",
    "ambiguityNotes": null,
    "horizon": "event-driven",
    "isExplicitTrade": false,
    "notFinancialAdvice": true,
    "disclaimer": "AISO tracks public statements, not verified portfolio positions. This is not financial advice."
  },
  "expert": {
    "slug": "investlikebest",
    "displayName": "Invest Like the Best",
    "kind": "PERSON",
    "status": "UNCLAIMED",
    "avatarUrl": "/api/avatars/75a94db5-5",
    "url": "/trace/experts/investlikebest",
    "claimed": false
  },
  "source": {
    "platform": "YOUTUBE",
    "title": "GLP-1s, Peptides, and The Trillion-Dollar Health Revolution",
    "sourceUrl": "https://youtube.com/watch?v=QVSP8bGm2KQ",
    "publishedAt": "2026-04-21T12:00:58.000Z"
  },
  "evidence": {
    "evidenceUrl": "https://www.youtube.com/watch?v=QVSP8bGm2KQ&t=428s",
    "sourceUrl": "https://youtube.com/watch?v=QVSP8bGm2KQ",
    "timecode": "7:08",
    "startMs": 428000,
    "endMs": null,
    "excerpt": "We've got amazing GLP-1 medicines... from clear data out of Eli Lilly, show a 94% reduction in your risk of moving from being pre-diabetic to diabetic.",
    "quote": "We've got amazing GLP-1 medicines... from clear data out of Eli Lilly, show a 94% reduction in your risk of moving from being pre-diabetic to diabetic.",
    "speaker": "Alex Karnal"
  },
  "entities": [
    {
      "kind": "ASSET",
      "assetClass": "EQUITY",
      "symbol": "LLY",
      "name": "LLY",
      "exchange": null,
      "confidence": 0.78
    }
  ],
  "marketData": {
    "entry": {
      "price": 930.01,
      "currency": "USD",
      "observedAt": "2026-04-21T12:00:58.000Z",
      "method": "PASTE_AUTHOR_PRICE"
    },
    "current": null,
    "returnPct": null
  },
  "snapshots": [
    {
      "kind": "ENTRY",
      "symbol": "LLY",
      "assetClass": "EQUITY",
      "price": 930.01,
      "probability": null,
      "currency": "USD",
      "provider": "paste.trade",
      "providerSymbol": "xyz:LLY",
      "observedAt": "2026-04-21T12:00:58.000Z",
      "method": "PASTE_AUTHOR_PRICE",
      "returnPct": null,
      "relativePct": null
    }
  ]
}

AISO Market Calls classifies public statements from public sources. A classification such as long thesis, short thesis, or explicit call describes the content of the public statement and does not prove that the speaker actually entered, exited, or held a position. Market performance shown is calculated from public market data around the source publication or timestamp. It is not investment advice.